High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.

Twenty-three patients with advanced NSCLC were treated with high dose chemotherapy using four agents and autologous bone marrow reinfusion. Ten patients received two bolus doses of cyclophosphamide (maximum tolerated total dose 10 G m-2), ifosfamide as a 24 h infusion (11 G m-2) followed by mitomyci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomm, S. A., Thatcher, N., Cuthbert, A., Chang, J., Burmester, H., Hall, P., Carroll, K. B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971797/
https://www.ncbi.nlm.nih.gov/pubmed/1847648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971797/
https://www.ncbi.nlm.nih.gov/pubmed/1847648

Ejemplares similares